NCT02839915: Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder
- State
- Under way
- Phase
- Phase 2
- People
- 56 taking part
- Started
- 13 Aug 2020
- Primary completion
- 15 Apr 2024
- Arms
- Folinic Acid
- Results
- None posted
- 21 Jul 2016: Trial registered
- 13 Aug 2020: Trial started